Neuropathy from Chemotherapy May Be Eased with Anti-Anxiety Drug
Chemotherapy is a cancer treatment method that may create additional disabling conditions. One of the side effects of chemotherapy treatments may be peripheral neuropathy which causes numbness, tingling or burning sensations in the extremities.
Severe peripheral neuropathy can be extremely painful and even cause loss of sensation which may lead to accidental injury from an inability to sense pain. Recently, researchers at the University of Michigan School or Nursing in Ann Arbor have found that a particular drug may help ease the pain of chemotherapy-acquired peripheral neuropathy.
The depression and anxiety drug duloxetine may reduce the pain experienced from peripheral neuropathy in patients undergoing chemotherapy treatment, the researchers found. In the five week study, 59 percent of patients initially treated with duloxetine reported a decrease in pain, compared to only 38 percent of the patients who initially received a placebo drug for pain management.
Many forms of cancer are considered to be disabling conditions on their own, and when a patient undergoes chemotherapy he or she may develop additional disabling conditions due to the medications used in treatment. Some of the issues chemotherapy patients may face include
- chronic fatigue;
- weakened immune system (more prone to infections); and
- memory changes.
When disabling conditions such as these occur, long-term disability benefits may be available to those who are unable to work and perform substantial gainful activity.
We Offer Help Obtaining Your Long-Term Disability Benefits
The National Cancer Institute estimated that 1.6 million people would be diagnosed with cancer in 2012. Chemotherapy treatment may be necessary to treat many cases of cancer, both new and old. If you are experiencing disabling conditions related to cancer you may qualify for long-term disability benefits. For help with a disability claim, contact the Disability Help Group Call today – 1-(800)-800-3332.